← 產業報告目錄
Pharmacovigilance Market Size, Share & Trends Analysis Report By Service Provider (In-House And Contract Outsourcing), Product Life Cycle (Pre-Clinical, Phase I, Phase II, Phase III And Phase IV), By Type, By Process Flow, By Therapeutic Area, And By End-Use, By Region, And Segment Forecasts, 2025-2034
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-02-25頁數 180報告編號 INSIGHTACE-83eadc23f8
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
The Pharmacovigilance Market on a global scale was estimated at USD 7.8 Bn in 2024 and is expected to attain USD 15.3 Bn by 2034, with a projected CAGR of 7.1% between 2025 and 2034.
The Pharmacovigilance sector involves dynamics.
Several factors contribute to this trajectory, including heightened need next-generation products, expanding applications across diverse end-use sectors, and supportive government initiatives.
From a segmentation standpoint, the market is categorized across multiple dimensions including product type, application, end-user, and geography, each exhibiting distinct growth patterns and opportunities.
Geographically, North America maintains a leading position owing to advanced infrastructure, high R&D expenditure, and a well-established regulatory environment. Meanwhile, Asia-Pacific is emerging as the fastest-growing region, propelled by rapid industrialization and expanding end-user bases.
The competitive arena features a mix of established conglomerates and agile innovators, each vying for market position through strategic acquisitions, product launches, and capacity expansion.
This comprehensive research study delivers granular insights into market sizing, trend analysis, competitive benchmarking, and forward-looking projections to support strategic decision-making for industry participants and investors.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Pharmacovigilance Market Snapshot
Chapter 4. Global Pharmacovigilance Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Product Life Cycle Estimates & Trend Analysis
5.1. by Product Life Cycle & Market Share, 2024 & 2034
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Product Life Cycle:
5.2.1. Pre-clinical
5.2.2. Phase I
5.2.3. Phase II
5.2.4. Phase III
5.2.5. Phase IV
Chapter 6. Market Segmentation 2: by Service Provider Estimates & Trend Analysis
6.1. by Service Provider & Market Share, 2024 & 2034
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Service Provider:
6.2.1. In-house
6.2.2. Contract Outsourcing
Chapter 7. Market Segmentation 3: by Type Estimates & Trend Analysis
7.1. by Type & Market Share, 2024 & 2034
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Type:
7.2.1. Spontaneous Reporting
7.2.2. Intensified ADR Reporting
7.2.3. Targeted Spontaneous Reporting
7.2.4. Cohort Event Monitoring
7.2.5. EHR Mining
Chapter 8. Market Segmentation 4: by Process Flow Estimates & Trend Analysis
8.1. by Process Flow & Market Share, 2024 & 2034
8.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Process Flow:
8.2.1. Case Data Management
8.2.1.1. Case Logging
8.2.1.2. Case Data Analysis
8.2.1.3. Medical Reviewing & Reporting
8.2.2. Signal Detection
8.2.2.1. Adverse Event Logging
8.2.2.2. Adverse Event Analysis
8.2.2.3. Adverse Event Review & Reporting
8.2.3. Risk Management System
8.2.3.1. Risk Evaluation System
8.2.3.2. Risk Mitigation System
Chapter 9. Market Segmentation 5: by Therapeutic Area Estimates & Trend Analysis
9.1. by Therapeutic Area & Market Share, 2024 & 2034
9.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Therapeutic Area:
9.2.1. Oncology
9.2.2. Neurology
9.2.3. Cardiology
9.2.4. Respiratory Systems
9.2.5. Others
Chapter 10. Market Segmentation 6: by End-use Estimates & Trend Analysis
10.1. by End-use & Market Share, 2024 & 2034
10.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by End-use:
10.2.1. Pharmaceuticals
10.2.2. Biotechnology Companies
10.2.3. Medical Device Manufacturers
10.2.4. Others
Chapter 11. Pharmacovigilance Market Segmentation 7: Regional Estimates & Trend Analysis
11.1. North America
11.1.1. North America Pharmacovigilance Market Revenue (US$ Million) Estimates and Forecasts by Product Life Cycle, 2021-2034
11.1.2. North America Pharmacovigilance Market Revenue (US$ Million) Estimates and Forecasts by Service Provider, 2021-2034
11.1.3. North America Pharmacovigilance Market Revenue (US$ Million) Estimates and Forecasts by Type, 2021-2034
11.1.4. North America Pharmacovigilance Market Revenue (US$ Million) Estimates and Forecasts by Process Flow, 2021-2034
11.1.5. North America Pharmacovigilance Market Revenue (US$ Million) Estimates and Forecasts by Therapeutic Area, 2021-2034
11.1.6. North America Pharmacovigilance Market Revenue (US$ Million) Estimates and Forecasts by End-use, 2021-2034
11.1.7. North America Pharmacovigilance Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
11.2. Europe
11.2.1. Europe Pharmacovigilance Market Revenue (US$ Million) Estimates and Forecasts by Product Life Cycle, 2021-2034
11.2.2. Europe Pharmacovigilance Market Revenue (US$ Million) Estimates and Forecasts by Service Provider, 2021-2034
11.2.3. Europe Pharmacovigilance Market Revenue (US$ Million) Estimates and Forecasts by Type, 2021-2034
11.2.4. Europe Pharmacovigilance Market Revenue (US$ Million) Estimates and Forecasts by Process Flow, 2021-2034
11.2.5. Europe Pharmacovigilance Market Revenue (US$ Million) Estimates and Forecasts by Therapeutic Area, 2021-2034
11.2.6. Europe Pharmacovigilance Market Revenue (US$ Million) Estimates and Forecasts by End-use, 2021-2034
11.2.7. Europe Pharmacovigilance Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
11.3. Asia Pacific
11.3.1. Asia Pacific Pharmacovigilance Market Revenue (US$ Million) Estimates and Forecasts by Product Life Cycle, 2021-2034
11.3.2. Asia Pacific Pharmacovigilance Market Revenue (US$ Million) Estimates and Forecasts by Service Provider, 2021-2034
11.3.3. Asia-Pacific Pharmacovigilance Market Revenue (US$ Million) Estimates and Forecasts by Type, 2021-2034
11.3.4. Asia-Pacific Pharmacovigilance Market Revenue (US$ Million) Estimates and Forecasts by Process Flow, 2021-2034
11.3.5. Asia Pacific Pharmacovigilance Market Revenue (US$ Million) Estimates and Forecasts by Therapeutic Area, 2021-2034
11.3.6. Asia Pacific Pharmacovigilance Market Revenue (US$ Million) Estimates and Forecasts by End-use, 2021-2034
11.3.7. Asia Pacific Pharmacovigilance Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
11.4. Latin America
11.4.1. Latin America Pharmacovigilance Market Revenue (US$ Million) Estimates and Forecasts by Product Life Cycle, 2021-2034
11.4.2. Latin America Pharmacovigilance Market Revenue (US$ Million) Estimates and Forecasts by Service Provider, 2021-2034
11.4.3. Latin America Pharmacovigilance Market Revenue (US$ Million) Estimates and Forecasts by Type, 2021-2034
11.4.4. Latin America Pharmacovigilance Market Revenue (US$ Million) Estimates and Forecasts by Process Flow, 2021-2034
11.4.5. Latin America Pharmacovigilance Market Revenue (US$ Million) Estimates and Forecasts by Therapeutic Area, 2021-2034
11.4.6. Latin America Pharmacovigilance Market Revenue (US$ Million) Estimates and Forecasts by End-use, 2021-2034
11.4.7. Latin America Pharmacovigilance Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
11.5. Middle East & Africa
11.5.1. Middle East & Africa Pharmacovigilance Market Revenue (US$ Million) Estimates and Forecasts by Product Life Cycle, 2021-2034
11.5.2. Middle East & Africa Pharmacovigilance Market Revenue (US$ Million) Estimates and Forecasts by Service Provider, 2021-2034
11.5.3. Middle East & Africa Pharmacovigilance Market Revenue (US$ Million) Estimates and Forecasts by Type, 2021-2034
11.5.4. Middle East & Africa Pharmacovigilance Market Revenue (US$ Million) Estimates and Forecasts by Process Flow, 2021-2034
11.5.5. Middle East & Africa Pharmacovigilance Market Revenue (US$ Million) Estimates and Forecasts by Therapeutic Area, 2021-2034
11.5.6. Middle East & Africa Pharmacovigilance Market Revenue (US$ Million) Estimates and Forecasts by End-use, 2021-2034
11.5.7. Middle East & Africa Pharmacovigilance Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
Chapter 12. Competitive Landscape
12.1. Major Mergers and Acquisitions/Strategic Alliances
12.2. Company Profiles
12.2.1. Meta Service Providers, Inc.
12.2.2. Tencent Holdings Ltd.
12.2.3. ByteDance Ltd.
12.2.4. NetEase, Inc.
12.2.5. Nvidia Corporation
12.2.6. Epic Games, Inc.
12.2.7. Roblox Corporation
12.2.8. Unity Technologies, Inc.
12.2.9. Lilith Games
12.2.10. Nextech AR Solutions Corp.
12.2.11. The Sandbox
12.2.12. Active Theory
12.2.13. Decentraland
12.2.14. Microsoft Corporation
12.2.15. Antier Solutions Pvt. Ltd.
12.2.16. Other Prominent Players
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們